Quercetin attenuates chronic ethanol hepatotoxicity: Implication of "free" iron uptake and release

Food and Chemical Toxicology

Volumn 67, Issue , 2014, Pages 131-138

  Tang, Yuhan ^a   Li, Yanyan ^a   Yu, Haiyan ^a   Gao, Chao ^a   Liu, Liang ^a   Xing, Mingyou ^a   Yao, Ping ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Alcoholic liver disease (ALD); Labile iron pool Fe (LIP Fe); Non transferrin bound iron (NTBI); Oxidative stress; Quercetin

Indexed keywords

ALCOHOL; CARRIER PROTEIN; CD71 ANTIGEN; FREE IRON; IRON; METAL TRANSPORTER 1; MUCOLIPIN 1; QUERCETIN; UNCLASSIFIED DRUG; ZINC TRANSPORTER MEMBER 14; PRIMER DNA;

ADULT; ALCOHOL CONSUMPTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; C57BL MOUSE; CHRONIC TOXICITY; IRON METABOLISM; IRON RELEASE; IRON TRANSPORT; LIVER LEVEL; LIVER PROTECTION; LIVER TOXICITY; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; PROTEIN EXPRESSION; UPREGULATION; ANIMAL; DRUG EFFECTS; LIVER; METABOLISM; REAL TIME POLYMERASE CHAIN REACTION; TOXICITY;

ANIMALS; BASE SEQUENCE; DNA PRIMERS; ETHANOL; IRON; LIVER; MALE; MICE; MICE, INBRED C57BL; QUERCETIN; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84896269207     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2014.02.022     Document Type: Article

References (50)

1. Anderson G.J., Vulpe C.D. Mammalian iron transport. Cell. Mol. Life Sci. 2009, 66:3241-3261.
2. Basu-Modak S., Ali D., Gordon M., Polte T., Yiakouvaki A., Pourzand C., Rice-Evans C., Tyrrell R.M. Suppression of UVA-mediated release of labile iron by epicatechin - a link to lysosomal protection. Free Radic. Biol. Med. 2006, 41:1197-1204.
3. Bischoff S.C. Quercetin: potentials in the prevention and therapy of disease. Curr. Opin. Clin. Nutr. Metab. Care 2008, 11:733-740.
4. Boots A.W., Haenen G.R., Bast A. Health effects of quercetin: from antioxidant to nutraceutical. Eur. J. Pharmacol. 2008, 585:325-337.
5. Breitkopf K., Nagy L.E., Beier J.I., Mueller S., Weng H., Dooley S. Current experimental perspectives on the clinical progression of alcoholic liver disease. Alcohol. Clin. Exp. Res. 2009, 33:1647-1655.
6. Breuer W., Cabantchik Z.I. A fluorescence-based one-step assay for serum non-transferrin-bound iron. Anal. Biochem. 2001, 299:194-202.
7. Brissot P., Ropert M., Le Lan C., Loreal O. Non-transferrin bound iron: a key role in iron overload and iron toxicity. Biochim. Biophys. Acta 2012, 1820:403-410.
8. Buege J.A., Aust S.D. Microsomal lipid peroxidation. Meth. Enzymol. 1978, 52:302-310.
9. Carter W.O., Narayanan P.K., Robinson J.P. Intracellular hydrogen peroxide and superoxide anion detection in endothelial cells. J. Leukoc. Biol. 1994, 55:253-258.
10. Chen X. Protective effects of quercetin on liver injury induced by ethanol. Pharmacogn. Mag. 2010, 6:135-141.
11. De Feo T.M., Fargion S., Duca L., Cesana B.M., Boncinelli L., Lozza P., Cappellini M.D., Fiorelli G. Non-transferrin-bound iron in alcohol abusers. Alcohol Clin. Exp. Res. 2001, 25:1494-1499.
12. Dey A., Cederbaum A.I. Alcohol and oxidative liver injury. Hepatology 2006, 43:S63-S74.
13. Dong X.P., Cheng X., Mills E., Delling M., Wang F., Kurz T., Xu H. The type IV mucolipidosis-associated protein TRPML1 is an endolysosomal iron release channel. Nature 2008, 455:992-996.
14. Friedman A., Arosio P., Finazzi D., Koziorowski D., Galazka-Friedman J. Ferritin as an important player in neurodegeneration. Parkinsonism Relat. Disord. 2011, 17:423-430.
15. Greenberg G.R., Wintrobe M.M. A labile iron pool. J. Biol. Chem. 1946, 165:397.
16. Harrison-Findik D.D., Klein E., Crist C., Evans J., Timchenko N., Gollan J. Iron-mediated regulation of liver hepcidin expression in rats and mice is abolished by alcohol. Hepatology 2007, 46:1979-1985.
17. Hasebe Y., Egawa K., Yamazaki Y., Kunimoto S., Hirai Y., Ida Y., Nose K. Specific inhibition of hypoxia-inducible factor (HIF)-1 alpha activation and of vascular endothelial growth factor (VEGF) production by flavonoids. Biol. Pharm. Bull. 2003, 26:1379-1383.
18. Hershko C., Graham G., Bates G.W., Rachmilewitz E.A. Non-specific serum iron in thalassaemia: an abnormal serum iron fraction of potential toxicity. Br. J. Haematol. 1978, 40:255-263.
19. Jomova K., Valko M. Advances in metal-induced oxidative stress and human disease. Toxicology 2011, 283:65-87.
20. Khan M.F., Wu X., Alcock N.W., Boor P.J., Ansari G.A. Iron exacerbates aniline-associated splenic toxicity. J. Toxicol. Environ. Health A 1999, 57:173-184.
21. Leopoldini M., Russo N., Chiodo S., Toscano M. Iron chelation by the powerful antioxidant flavonoid quercetin. J. Agric. Food Chem. 2006, 54:6343-6351.
22. Li Z., Lai Z., Ya K., Fang D., Ho Y.W., Lei Y., Ming Q.Z. Correlation between the expression of divalent metal transporter 1 and the content of hypoxia-inducible factor-1 in hypoxic HepG2 cells. J. Cell. Mol. Med. 2008, 12:569-579.
23. Li P.G., Sun L., Han X., Ling S., Gan W.T., Xu J.W. Quercetin induces rapid eNOS phosphorylation and vasodilation by an Akt-independent and PKA-dependent mechanism. Pharmacology 2012, 89:220-228.
24. Liuzzi J.P., Lichten L.A., Rivera S., Blanchard R.K., Aydemir T.B., Knutson M.D., Ganz T., Cousins R.J. Interleukin-6 regulates the zinc transporter Zip14 in liver and contributes to the hypozincemia of the acute-phase response. Proc. Natl. Acad. Sci. USA 2005, 102:6843-6848.
25. Liuzzi J.P., Aydemir F., Nam H., Knutson M.D., Cousins R.J. Zip14 (Slc39a14) mediates non-transferrin-bound iron uptake into cells. Proc. Natl. Acad. Sci. USA 2006, 103:13612-13617.
26. Lowry O.H., Rosebrough N.J., FARR A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951, 193:265-275.
27. MacKenzie E.L., Iwasaki K., Tsuji Y. Intracellular iron transport and storage: from molecular mechanisms to health implications. Antioxid. Redox Signal 2008, 10:997-1030.
28. Manach C., Williamson G., Morand C., Scalbert A., Remesy C. Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am. J. Clin. Nutr. 2005, 81:230-242.
29. Mladenka P., Macakova K., Filipsky T., Zatloukalova L., Jahodar L., Bovicelli P., Silvestri I.P., Hrdina R., Saso L. In vitro analysis of iron chelating activity of flavonoids. J. Inorg. Biochem. 2011, 105:693-701.
30. Moron M.S., Depierre J.W., Mannervik B. Levels of glutathione, glutathione reductase and glutathione S-transferase activities in rat lung and liver. Biochim. Biophys. Acta 1979, 582:67-78.
31. Park S.S., Bae I., Lee Y.J. Flavonoids-induced accumulation of hypoxia-inducible factor (HIF)-1alpha/2alpha is mediated through chelation of iron. J. Cell. Biochem. 2008, 103:1989-1998.
32. Punithavathi V.R., Prince P.S. Pretreatment with a combination of quercetin and alpha-tocopherol ameliorates adenosine triphosphatases and lysosomal enzymes in myocardial infarcted rats. Life Sci. 2010, 86:178-184.
33. Rapisarda C., Puppi J., Hughes R.D., Dhawan A., Farnaud S., Evans R.W., Sharp P.A. Transferrin receptor 2 is crucial for iron sensing in human hepatocytes. Am. J. Physiol. Gastrointest. Liver Physiol. 2010, 299:G778-G783.
34. Rehm J., Mathers C., Popova S., Thavorncharoensap M., Teerawattananon Y., Patra J. Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders. Lancet 2009, 373:2223-2233.
35. Ren Y., Deng F., Zhu H., Wan W., Ye J., Luo B. Effect of epigallocatechin-3-gallate on iron overload in mice with alcoholic liver disease. Mol. Biol. Rep. 2011, 38:879-886.
36. Sarkar A., Angeline M.S., Anand K., Ambasta R.K., Kumar P. Naringenin and quercetin reverse the effect of hypobaric hypoxia and elicit neuroprotective response in the murine model. Brain Res. 2012, 1481:59-70.
37. Sergent O., Tomasi A., Ceccarelli D., Masini A., Nohl H., Cillard P., Cillard J., Vladimirov Y.A., Kozlov A.V. Combination of iron overload plus ethanol and ischemia alone give rise to the same endogenous free iron pool. Biometals 2005, 18:567-575.
38. Sestili P., Guidarelli A., Dacha M., Cantoni O. Quercetin prevents DNA single strand breakage and cytotoxicity caused by tert-butylhydroperoxide: free radical scavenging versus iron chelating mechanism. Free Radic. Biol. Med. 1998, 25:196-200.
39. Shindo M., Torimoto Y., Saito H., Motomura W., Ikuta K., Sato K., Fujimoto Y., Kohgo Y. Functional role of DMT1 in transferrin-independent iron uptake by human hepatocyte and hepatocellular carcinoma cell HLF. Hepatol. Res. 2006, 35:152-162.
40. Tang Y.H., Gao C., Shi Y.R., Zhu L.P., Hu X.M., Wang D., Lv Y., Yang X.F., Liu L.G., Yao P. Quercetin attenuates ethanol-derived microsomal oxidative stress: implication of haem oxygenase-1 induction. Food Chem. 2012, 132:1769-1774.
41. Vergarajauregui S., Oberdick R., Kiselyov K., Puertollano R. Mucolipin 1 channel activity is regulated by protein kinase A-mediated phosphorylation. Biochem. J. 2008, 410:417-425.
42. Vlachodimitropoulou E., Sharp P.A., Naftalin R.J. Quercetin-iron chelates are transported via glucose transporters. Free Radic. Biol. Med. 2011, 50:934-944.
43. Wang D., Wang L.H., Zhao Y., Lu Y.P., Zhu L. Hypoxia regulates the ferrous iron uptake and reactive oxygen species level via divalent metal transporter 1 (DMT1) Exon1B by hypoxia-inducible factor-1. IUBMB Life 2010, 62:629-636.
44. Wu D., Cederbaum A.I. Oxidative stress mediated toxicity exerted by ethanol-inducible CYP2E1. Toxicol. Appl. Pharmacol. 2005, 207:70-76.
45. Yao P., Hao L., Nussler N., Lehmann A., Song F., Zhao J., Neuhaus P., Liu L., Nussler A. The protective role of HO-1 and its generated products (CO, bilirubin, and Fe) in ethanol-induced human hepatocyte damage. Am. J. Physiol. Gastrointest. Liver Physiol. 2009, 296:G1318-G1323.
46. Yoon J.S., Chae M.K., Lee S.Y., Lee E.J. Anti-inflammatory effect of quercetin in a whole orbital tissue culture of Graves' orbitopathy. Br. J. Ophthalmol. 2012, 96:1117-1121.
47. Zhang H. Epidemiology of alcoholic liver diseases. Zhonghua. Gan. Zang. Bing. Za. Zhi. 2003, 11:689.
48. Zhang Y., Li H., Zhao Y., Gao Z. Dietary supplementation of baicalin and quercetin attenuates iron overload induced mouse liver injury. Eur. J. Pharmacol. 2006, 535:263-269.
49. Zhang Y., Gao Z., Liu J., Xu Z. Protective effects of baicalin and quercetin on an iron-overloaded mouse: comparison of liver, kidney and heart tissues. Nat. Prod. Res. 2011, 25:1150-1160.
50. Zoller H., Koch R.O., Theurl I., Obrist P., Pietrangelo A. Expression of the duodenal iron transporters divalent-metal transporter 1 and ferroportin 1 in iron deficiency and iron overload. Gastroenterology 2001, 120:1412-1419.